Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP
Executive Summary
The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5